46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
52.10.B - Warehousing and storage of other goods
82.92.Z - Packaging activities
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 4,2 | 1,1 | -73,4 | |
Gross profit (loss) | 14,7 | 4,7 | 1,7 | -63,2 |
EBITDA | 14,4 | 4,6 | 1,3 | -71,2 |
Short time liabilities | 4 | 0,9 | 1,5 | 56,5 |
Other operating costs | 0,4 | 0,4 | -8,9 | |
Equity capital | 39,8 | 34,4 | 24,4 | -28,9 |
Operating profit (EBIT) | 14,1 | 4,3 | 1,1 | -73,8 |
Assets | 43,8 | 35,4 | 25,9 | -26,7 |
Net profit (loss) | 11,8 | 3,8 | 1,3 | -65,1 |
Cash | 19,7 | 1,6 | 1,1 | -30,9 |
Liabilities and provisions for liabilities | 4 | 1 | 1,5 | 50,9 |
Net income from sale | 82,1 | 37 | 28,3 | -23,6 |
Working assets | 40,3 | 32,1 | 22,9 | -28,6 |
Other income costs | 0,5 | 0,4 | -25 | |
Depreciation | 0,3 | 0,3 | 0,2 | -28,7 |
% | % | % | p.p. | |
Profitability of capital | 29,6 | 11 | 5,4 | -5,6 |
Equity capital to total assets | 90,8 | 97,2 | 94,3 | -2,9 |
Gross profit margin | 17,8 | 12,6 | 6,1 | -6,5 |
EBITDA Margin | 17,5 | 12,4 | 4,7 | -7,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | 9 | 19 | 10 |
Current financial liquidity indicator | 33.959808349609375 | 15.497903823852539 | -18,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane